Clinical Trial Update: Increlex Treatment of Children With Chronic Liver Disease and Short Stature [NA]

View source ↗

Summary

A pediatric trial of Increlex (mecasermin) for growth failure associated with chronic liver disease has been withdrawn. The study was sponsored by the Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Failure
• Liver Disease

Drugs mentioned

• INCRELEX (Mecasermin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Growth Failure, Chronic Liver Disease | NA | Status: WITHDRAWN